A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

Midyett, Kurt; Unger, Jeffrey; Wright, Eugene; Daniel, Timothy D.; Kruger, Davida F.; Henry, Robert R.; Hegazi, Refaat

doi:10.2337/cd18-0006

Cited by 7 publications

(9 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The use of a two‐part CGM SMA demonstrated significant improvements in diabetes self‐efficacy and A1C. Previous literature has cited mean scores on the self‐efficacy survey tool as 5.17 ± 2.22, with increases in self‐efficacy scores by 0.12 to 0.49 points after participation in a six week small‐group DSMES program 20,21 . The baseline and follow‐up self‐efficacy scores of participants in our study were well above this range.…”

Section: Discussionsupporting

confidence: 61%

“…A sample size of 19 participants per group were needed for an adequate power of 0.80 and an alpha of .05 to detect a 1 point change in mean scores. This survey has good reliability (Cronbach's α = .85) and test‐retest validity of 0.80 in the general adult diabetes population 20,21 . In this study, there was good internal consistency (Cronbach's α = .89).…”

Section: Methodsmentioning

confidence: 60%

“…Previous literature on professional CGM is mostly retrospective and has demonstrated minor changes in A1C 16‐19 . A study by Midyett and colleagues evaluated the “real world” impact of professional CGM in people with type 2 diabetes and showed that providers were confident in recommending changes in diabetes management without large amounts of participant‐reported data 20 …”

mentioning

confidence: 99%

See 2 more Smart Citations

Continuous glucose monitoring shared medical appointments improve diabetes self‐efficacy and hemoglobin A1C

Simonyan

Isaacs

Lekic

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionDiabetes self‐management education and support and professional continuous glucose monitoring (CGM) were combined into shared medical appointments (SMA) to provide care for people with diabetes. Although the individual components have evidence of efficacy, this combination has never been studied.ObjectivesThe purpose of this study is to assess the impact of CGM SMA on diabetes self‐efficacy and hemoglobin A1C (A1C) in persons with diabetes.MethodsAdults who attended a two‐part CGM SMA at a large academic medical center were included in this retrospective, pre‐post study. The CGM SMA incorporated diabetes education, peer support, and seven days of professional CGM. The primary outcome was change in diabetes self‐efficacy through a validated eight‐item Likert Scale instrument. Secondary objectives were changes in A1C, changes in diabetes medications, and type of planned lifestyle changes. Paired t tests were used to analyze change in A1C and diabetes self‐efficacy scores.ResultsA total of 171 participants were included in this analysis. Diabetes self‐efficacy scores increased by a mean of 1.63 ± 2.09 points (P < .001) out of 10 points maximum after participation in the two‐part CGM SMA. The A1C decreased by a mean of 0.80 ± 1.52% (P < .001), with a mean follow‐up A1C of 7.8 ± 1.60%. Those with an A1C > 8% (n = 101) experienced a decrease of 1.20%. Participants utilizing the unblinded device (n = 133) experienced a decrease in A1C by 0.75% compared with 1.0% in those that utilized a blinded device (n = 38). Most medication changes made in the CGM SMA were dosage adjustments and changes in administration time.ConclusionsThe CGM SMA is a novel practice model incorporating diabetes education, peer support, professional CGM, and interprofessional care that demonstrated improvements in diabetes self‐efficacy and A1C.

show abstract

Section: Discussionsupporting

confidence: 61%

Section: Methodsmentioning

confidence: 60%

mentioning

confidence: 99%

See 1 more Smart Citation

Continuous glucose monitoring shared medical appointments improve diabetes self‐efficacy and hemoglobin A1C

Simonyan

Isaacs

Lekic

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…Moreover, safety assessment confirmed that FGM technology is an effective and safe substitute for blood glucose monitoring, provided that the patient is confident in the use of the technology and has a minimum average sensor scanning of eight times per day [55]. In fact, FGM use seems to have a clinical good acceptance by patients with T2D and clinicians [56]. Using AGP derived from FGM downloading to review glycemic profiles and to consider treatment adjustments, is associated with significant reductions in HbA1c levels also in T2D subjects due to a rapid and sustained reduction of hyperglycemia [57,58].…”

Section: Cgm and T2dmentioning

confidence: 86%

Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?

Pedone

Laurenzi

Allora

et al. 2020

Exploration of Medicine

View full text Add to dashboard Cite

Technology in diabetes is rapidly evolving, with the aim of helping affected people to safely optimize their blood glucose control. New technologies are now considered as an essential tool for managing glycemia predominantly in people with type 1 diabetes, and clinical trials have demonstrated that in these subjects the use of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) systems are associated with improved glycemic control along with a better quality of life. Literature regarding technologies and type 2 diabetes is relatively lacking, but innovations may have an important role also in the management of these patients. Some studies in adults with type 2 diabetes have shown benefits with the use of CGM in terms of glycemic variability and improved therapeutic adjustments. Clinical trials about CSII and CGM use in type 2 diabetes may have some pitfalls and future studies are needed to assess how these advanced systems could improve clinical outcomes and also ensure cost-effectiveness in this population. In this narrative review, we aim to highlight the most relevant studies on this topic and to focus on the potential role of new technological devices in type 2 diabetes management.

show abstract

“…Diabetes Mellitus (DM) merupakan sebuah penyakit, di mana kondisi kadar glukosa (gula sederhana) di dalam darah melebihi batas normal (Mahdiana, 2010). Variabilitas glukosa merupakan faktor risiko potensial independen dari hasil klinis yang buruk diantara orang dengan diabetes (Kurt Midyett, dkk, 2019). DM merupakan penyakit dengan segudang komplikasi.…”

Section: Pendahuluanunclassified

Pelaksanaan Self Monitoring of Blood Glucose pada Pasien DM Tipe 2 di Kota Blitar

Sepdianto¹

2019

JKM

View full text Add to dashboard Cite

Self Monitoring of Blood Glucose merupakan pemeriksaan gula darah yang dilakukan sendiri oleh pasien diabetes mellitus. Tujuan penelitian ini untuk mendiskripsikan tentang pelaksanaan Self Monitoring of Blood Glucose. Desain penelitian menggunakan rancangan penelitian deskriptif dengan sampel 30 orang. Pengumpulan data dengan menggunakan lembar kuesioner dan observasi. Hasil penelitian menunjukkan bahwa pasien yang melakukan Self Monitoring of Blood Glucose adalah sebanyak 50% (15 pasien) (n=30) memiliki profil gula darah dalam rentang normal saat gula darah puasa sebanyak 53% (8 pasien) dan 2 jam post prandial sebanyak 73% (11 pasien) dengan tempat pelaksaan di rumah dan pelayanan kesehatan sebanyak 47% (14 pasien). Perlunya pelaksanaan Self Monitoring of Blood Glucose pada pasien Diabetes Mellitus untuk membantu pasien dalam mengontrol profil gula darah mereka.

show abstract

A Pilot Study to Assess Clinical Utility and User Experience of Professional Continuous Glucose Monitoring Among People With Type 2 Diabetes

Cited by 7 publications

References 24 publications

Continuous glucose monitoring shared medical appointments improve diabetes self‐efficacy and hemoglobin A1C

Continuous glucose monitoring shared medical appointments improve diabetes self‐efficacy and hemoglobin A1C

Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?

Pelaksanaan Self Monitoring of Blood Glucose pada Pasien DM Tipe 2 di Kota Blitar

Contact Info

Product

Resources

About